Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes

Clinical Cancer Research

Volumn 5, Issue 5, 1999, Pages 1115-1124

  Ries, Christian ^a   Loher, Florian ^a   Zang, Chuanbhig ^a,b   Ismair, Manfred G ^a,c   Petrides, Petro E ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA; MALE; MONONUCLEAR CELL; MULTIGENE FAMILY; MYELODYSPLASTIC SYNDROME; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

ACUTE DISEASE; ADULT; AGED; BLAST CRISIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BONE MARROW CELLS; CELLS, CULTURED; COLLAGENASES; CULTURE MEDIA, CONDITIONED; ENZYME INDUCTION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, MYELOID; LEUKEMIA, MYELOID, CHRONIC; MALE; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MIDDLE AGED; MONOCYTES; MYELODYSPLASTIC SYNDROMES; NEOPLASM PROTEINS; NEOPLASMS, SECOND PRIMARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELLS;

EID: 0032937216     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Sawyers, C. L., Denny, C. T., and Witte, O. N. Leukemia and the disruption of normal hematopoiesis. Cell, 64: 337-350, 1991.
2. Ries, C., and Petrides, P. E. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol. Chem. Hoppe-Seyler, 376: 345-355, 1995.
3. Nagase, H. Activation mechanisms of matrix metalloproteinases. Biol. Chem., 378: 151-160, 1997.
4. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature (Lond.), 370: 61-65, 1994.
5. Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327-336, 1991.
6. Stetler-Stevenson, W. G., Liotta, L. A., and Kleiner, D. E. J. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J., 7: 1434-1441, 1993.
7. Monteagudo, C., Merino, M. J., San Juan, J., Liotta, L. A., and Stetler Stevenson, W. G. Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am. J. Pathol., 136: 585-592, 1990.
8. r 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res, 51: 439-444, 1991.
9. Schultz, R. M., Silberman, S., Persky, B., Bajkowski, A. S., and Carmichael, D. F. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B 16-F10 melanoma cells. Cancer Res., 48: 5539-5545, 1988.
10. Otani, N., Tsukamoto, T., Saiki, I., Yoneda, J., Mitaka, T., and Kumamoto, Y. In vitro invasive potential and type IV collagenolytic activity of human renal cell carcinoma cells derived from primary and metastatic lesions. J. Urol., 149: 1182-1185, 1993.
11. Sato, H., Kida, Y., Mai, M., Endo, Y., Sasaki, T., Tanaka, J., and Seiki, M. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene, 7: 77-83, 1992.
12. Campo, E., Merino, M. J., Tavassoli, F. A., Charonis, A. S., Stetler Stevenson, W. G., and Liotta, L. A. Evaluation of basement membrane components and the 72 kDa type IV collagenase in serous tumors of the ovary. Am. J. Surg. Pathol., 16: 500-507, 1992.
13. r 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res., 52: 1336-1341, 1992.
14. Bernhard, E. J., Gruber, S. B., and Muschel, R. J. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/ collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. USA, 91: 4293-4297, 1994.
15. Brooks, P. C., Stromblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler Stevenson, W. G., Quigley, J. P., and Cheresh, D. A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell. 85: 683-693, 1996.
16. Masure, S., Proost, P., van Damme, J., and Opdenakker, G. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. Eur. J. Biochem., 198: 391-398, 1991.
17. Leppert, D., Waubant, E., Galardy, R., Bunnett, N. W., and Hauser, S. L. T cell gelatinases mediate basement membrane transmigration in vitro. J. Immunol., 154: 4379-4389, 1995.
18. Campbell, E. J., Cury, J. D., Shapiro, S. D., Goldberg, G. I., and Welgus, H. G. Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. J. Immunol., 146: 1286-1293, 1991.
19. Welgus, H. G., Campbell, E. J., Cury, J. D., Eisen, A. Z., Senior, R. M., Wilhelm, S. M., and Goldberg, G. I. Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J. Clin. Invest., 86: 1496-1502, 1990.
20. Goetzl, E. J., Banda, M. J., and Leppert, D. Matrix metalloproteinases in immunity. J. Immunol., 156: 1-4, 1996.
21. Stetler-Stevenson, M., Mansoor, A., Lim, M., Fukushima, P., Kehrl, J., Marti, G., Ptaszynski, K., Wang, J., and Stetler-Stevenson, W. G. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. Blood, 89: 1708-1715, 1997.
22. Kossakowska, A. E., Urbanski, S. J., Huchcroft, S. A., and Edwards, D. R. Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kDa gelatinase (type IV collagenase) and tissue inhibitor of metalloproteinases-1 (TIMP-1) RNAs. Oncol. Res., 4: 233-240, 1992.
23. Kossakowska, A. E., Urbanski, S. J., Watson, A., Hayden, L. J., and Edwards, D. R. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncol. Res., 5: 19-28, 1993.
24. Krüger, A., Fata, J. E., and Khokha, R. Altered tumor growth and metastasis of a T-cell lymphoma in TIMP-1 transgenic mice. Blood, 90: 1993-2000, 1997.
25. Guedez, L., Lim, M. S., and Stetler-Stevenson, W. G. The role of metalloproteinases and their inhibitors in hematological disorders. Crit. Rev. Oncogenesis, 7: 205-225, 1996.
26. Petrides, P. E., and Dittmann, K. H. How do normal and leukemic white blood cells egress from the bone marrow? Morphological facts and biochemical riddles. Ann. Hematol., 61: 3-13, 1990.
27. Ries, C., Kolb, H., and Petrides, P. E. Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-α as an autocrine stimulus for basal-and phorbol ester-induced secretion. Blood, 83: 3638-3646, 1994.
28. Ries, C., Lottspeich, F., Dittmann, K. H., and Petrides, P. E. HL-60 leukemia cells produce an autocatalytically truncated form of matrix metalloproteinase-9 with impaired sensitivity to inhibition by tissue inhibitors of metalloproteinases. Leukemia (Baltimore), 10: 1520-1526, 1996.
29. Ismair, M. G., Ries, C., Lottspeich, F., Zang, C., Kolb, H., and Petrides, P. E. Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-α (TNF-α) in NB4 leukemic cells: specific involvement of TNF receptor type I. Leukemia (Baltimore), 12: 1136-1143, 1998.
30. Matsuzaki, A., and Janowska-Wieczorek, A. Unstimulated human acute myelogenous leukemia blasts secrete matrix metalloproteinases. J. Cancer Res. Clin. Oncol., 123: 100-106, 1997.
31. Onisto, M., Riccio, M. P., Scannapieco, P., Caenazzo, C., Griggio, L., Spina, M., Stetler-Stevenson, W. G., and Garbisa, S. Gelatinase A/TIMP-2 imbalance in lymph-node-positive breast carcinomas, as measured by RT-PCR. Int. J. Cancer, 63: 621-626, 1995.
32. Yamamoto, M., Mohanam, S., Sawaya, R., Fuller, G. N., Seiki, M., Sato, H., Gokaslan, Z. L., Liotta, L. A., Nicolson, G. L., and Rao, J. S. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res., 56: 384-392, 1996.
33. Barille, S., Akhoundi, C., Collette, M., Mellerin, M. P., Rapp, M. J., Harousseau, J. L., Bateille, R., and Amiot, M. Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells. Blood, 90: 1649-1655, 1997.
34. Borregaard, N., Sehested, M., Nielsen, B. S., Sengelov, H., and Kjeldsen, L. Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood, 85: 812-817, 1995.
35. Saarialho Kere, U. K., Welgus, H. G., and Parks, W. C. Distinct mechanisms regulate interstitial collagenase and 92-kDa gelatinase expression in human monocytic-like cells exposed to bacterial endotoxin. J. Biol. Chem., 268: 17354-17361, 1993.
36. Van Ranst, M., Norga, K., Masure, S., Proost, P., Vandekerckhove, F., Auwerx, J., van Damme, J., and Opdenakker, G. The cytokine-protease connection: identification of a 96-kD THP-1 gelatinase and regulation by interleukin-1 and cytokine inducers. Cytokine, 3: 231-239, 1991.
37. Doherty, N. S., and Janusz, M. J. Neutrophil proteases: their physiological and pathological roles. In: P. G. Hellewell and T. J. Williams (eds.), Immunopharmacology of Neutrophils, pp. 55-94. London: Academic Press, 1994.
38. Delclaux, C., Delacourt, C., D'Ortho, M. P., Boyer, V., Lafuma, C., and Harf, A. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am. J. Respir. Cell Mol. Biol., 14: 288-295, 1996.
39. Laterveer, L., Lindley, I. J., Heemskerk, D. P., Camps, J. A., Pauwels, E. K., Willemze, R., and Fibbe, W. E. Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. Blood, 87: 781-788, 1996.
40. Pruijt, J. F. M., Fibbe, W. E., Laterveer, L., Willemze, R., Masure, S., Paemen, L., and Opdenakker, G. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by antibodies to the metalloproteinase gelatinase-B. Blood, 88: 455a, 1996.
41. Gearing, A. J., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., et al. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature (Lond.), 370: 555-557, 1994.
42. Kayagaki, N., Kawasaki, A., Ebata, T., Ohmoto, H., Ikeda, S., Inoue, S., Yoshino, K., Okumura, K., and Yagita, H. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med., 182: 1777-1783, 1995.
43. Nagase, H. Activation mechanisms of matrix metalloproteinases. Biol. Chem., 378: 151-160, 1997.
44. Wilhelm, S. M., Collier, I. E., Marmer, B. L., Eisen, A. Z., Grant, G. A., and Goldberg, G. I. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem., 264: 17213-17221, 1989.
45. Gasson, J. C., Golde, D. W., Kaufman, S. E., Westbrook, C. A., Hewick, R. M., Kaufman, R. J., Wong, G. G., Temple, P. A., Leary, A. C., Brown, E. L., et al. Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature (Lond.), 315: 768-771, 1985.
46. Avalos, B. R., Kaufman, S. E., Tomonaga, M., Williams, R. E., Golde, D. W., and Gasson, J. C. K562 cells produce and respond to human erythroid-potentiating activity. Blood, 71: 1720-1725, 1988.
47. Hayakawa, T., Yamashita, K., Tanzawa, K., Uchijima, E., and Iwata, K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett., 298: 29-32, 1992.
48. Kohn, E. C., and Liotta, L. A. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res., 55: 1856-1862, 1995.
49. Brown, P. D., and Giavazzi, R. Matrix metalloproteinase inhibition: a review of anti-tumour activity. Ann. Oncol., 6: 967-974, 1995.
50. Hattori, K., Hirano, T., Ushiyama, C., Miyajima, H., Yamakawa, N., Ebata, T., Wada, Y., Ikeda, S., Yoshino, K., Tateno, M., Oshimi, K., Kayagaki, N., Yagita, H., and Okumura, K. A metalloproteinase inhibitor prevents lethal acute graft-versus-host disease in mice. Blood, 90: 542-548, 1997.